Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia

NCT01118689 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed Multiple Myeloma
Refractory Multiple Myeloma
Waldenstrom Macroglobulinemia

Interventions

DRUG: MLN0128

Sponsor

Millennium Pharmaceuticals, Inc.